CYP 1.72% 29.5¢ cynata therapeutics limited

Ann: New Study to Investigate the High Potency of Cymerus MSCs, page-3

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    This study was likely guided by the FDAs decision regarding MSBs GVHD. Need to demonstrate the exact cellular mechanisms by which the MSCs cause effect. Then match this to in vitro testing of CYP product to demonstrate every dose will be equivocal in effect.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $52.99M
Open High Low Value Volume
28.0¢ 29.5¢ 27.5¢ $29.94K 106.4K

Buyers (Bids)

No. Vol. Price($)
1 1000 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 10159 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.